Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 65

1.

The effect of maternal obstructive sleep apnea on the placenta.

Kidron D, Bar-Lev Y, Tsarfaty I, Many A, Tauman R.

Sleep. 2019 Jun 11;42(6). pii: zsz072. doi: 10.1093/sleep/zsz072.

PMID:
30903184
2.

Mimp/Mtch2, an Obesity Susceptibility Gene, Induces Alteration of Fatty Acid Metabolism in Transgenic Mice.

Bar-Lev Y, Moshitch-Moshkovitz S, Tsarfaty G, Kaufman D, Horev J, Resau JH, Tsarfaty I.

PLoS One. 2016 Jun 30;11(6):e0157850. doi: 10.1371/journal.pone.0157850. eCollection 2016.

3.

Modeling the Transitions between Collective and Solitary Migration Phenotypes in Cancer Metastasis.

Huang B, Jolly MK, Lu M, Tsarfaty I, Ben-Jacob E, Onuchic JN.

Sci Rep. 2015 Dec 2;5:17379. doi: 10.1038/srep17379.

4.

The motility-proliferation-metabolism interplay during metastatic invasion.

Hecht I, Natan S, Zaritsky A, Levine H, Tsarfaty I, Ben-Jacob E.

Sci Rep. 2015 Sep 4;5:13538. doi: 10.1038/srep13538.

5.

Erratum: Tumor Invasion Optimization by Mesenchymal-Amoeboid Heterogeneity.

Hecht I, Bar-El Y, Balmer F, Natan S, Tsarfaty I, Schweitzer F, Ben-Jacob E.

Sci Rep. 2015 Jul 30;5:12121. doi: 10.1038/srep12121. No abstract available.

6.

Tumor invasion optimization by mesenchymal-amoeboid heterogeneity.

Hecht I, Bar-El Y, Balmer F, Natan S, Tsarfaty I, Schweitzer F, Ben-Jacob E.

Sci Rep. 2015 May 27;5:10622. doi: 10.1038/srep10622. Erratum in: Sci Rep. 2015;5:12121.

7.

Live time-lapse dataset of in vitro wound healing experiments.

Zaritsky A, Natan S, Kaplan D, Ben-Jacob E, Tsarfaty I.

Gigascience. 2015 Feb 25;4:8. doi: 10.1186/s13742-015-0049-6. eCollection 2015.

8.

MicroRNA miR-125a-3p modulates molecular pathway of motility and migration in prostate cancer cells.

Ninio-Many L, Grossman H, Levi M, Zilber S, Tsarfaty I, Shomron N, Tuvar A, Chuderland D, Stemmer SM, Ben-Aharon I, Shalgi R.

Oncoscience. 2014 Apr 30;1(4):250-261. eCollection 2014.

9.

Interplay Between HGF/SF-Met-Ras Signaling, Tumor Metabolism and Blood Flow as a Potential Target for Breast Cancer Therapy.

Natan S, Tsarfaty G, Horev J, Haklai R, Kloog Y, Tsarfaty I.

Oncoscience. 2013 Dec 11;1(1):30-38. eCollection 2014.

10.

Chemotherapy-induced vascular toxicity--real-time in vivo imaging of vessel impairment.

Bar-Joseph H, Stemmer SM, Tsarfaty I, Shalgi R, Ben-Aharon I.

J Vis Exp. 2015 Jan 7;(95):e51650. doi: 10.3791/51650.

11.

The three-way switch operation of Rac1/RhoA GTPase-based circuit controlling amoeboid-hybrid-mesenchymal transition.

Huang B, Lu M, Jolly MK, Tsarfaty I, Onuchic J, Ben-Jacob E.

Sci Rep. 2014 Sep 23;4:6449. doi: 10.1038/srep06449.

12.

Functional molecular imaging of tumors by chemical exchange saturation transfer MRI of 3-O-Methyl-D-glucose.

Rivlin M, Tsarfaty I, Navon G.

Magn Reson Med. 2014 Nov;72(5):1375-80. doi: 10.1002/mrm.25467. Epub 2014 Sep 18.

13.

Propagating waves of directionality and coordination orchestrate collective cell migration.

Zaritsky A, Kaplan D, Hecht I, Natan S, Wolf L, Gov NS, Ben-Jacob E, Tsarfaty I.

PLoS Comput Biol. 2014 Jul 24;10(7):e1003747. doi: 10.1371/journal.pcbi.1003747. eCollection 2014 Jul.

14.

Benchmark for multi-cellular segmentation of bright field microscopy images.

Zaritsky A, Manor N, Wolf L, Ben-Jacob E, Tsarfaty I.

BMC Bioinformatics. 2013 Nov 7;14:319. doi: 10.1186/1471-2105-14-319.

15.

Molecular imaging of tumors and metastases using chemical exchange saturation transfer (CEST) MRI.

Rivlin M, Horev J, Tsarfaty I, Navon G.

Sci Rep. 2013 Oct 25;3:3045. doi: 10.1038/srep03045.

16.

Met-induced membrane blebbing leads to amoeboid cell motility and invasion.

Laser-Azogui A, Diamant-Levi T, Israeli S, Roytman Y, Tsarfaty I.

Oncogene. 2014 Apr 3;33(14):1788-98. doi: 10.1038/onc.2013.138. Epub 2013 May 13.

PMID:
23665680
17.

The structure of anthracycline derivatives determines their subcellular localization and cytotoxic activity.

Shaul P, Frenkel M, Goldstein EB, Mittelman L, Grunwald A, Ebenstein Y, Tsarfaty I, Fridman M.

ACS Med Chem Lett. 2013 Feb 4;4(3):323-8. doi: 10.1021/ml3002852. eCollection 2013 Mar 14.

18.

Met kinetic signature derived from the response to HGF/SF in a cellular model predicts breast cancer patient survival.

Stein GY, Yosef N, Reichman H, Horev J, Laser-Azogui A, Berens A, Resau J, Ruppin E, Sharan R, Tsarfaty I.

PLoS One. 2012;7(9):e45969. doi: 10.1371/journal.pone.0045969. Epub 2012 Sep 25.

19.

Emergence of HGF/SF-induced coordinated cellular motility.

Zaritsky A, Natan S, Ben-Jacob E, Tsarfaty I.

PLoS One. 2012;7(9):e44671. doi: 10.1371/journal.pone.0044671. Epub 2012 Sep 6.

20.

Secrets of tubule engineering by epithelial cells.

Tsarfaty I, Ben-Jacob E.

Proc Natl Acad Sci U S A. 2012 May 1;109(18):6790-1. doi: 10.1073/pnas.1202337109. Epub 2012 Apr 23. No abstract available.

21.

Cell motility dynamics: a novel segmentation algorithm to quantify multi-cellular bright field microscopy images.

Zaritsky A, Natan S, Horev J, Hecht I, Wolf L, Ben-Jacob E, Tsarfaty I.

PLoS One. 2011;6(11):e27593. doi: 10.1371/journal.pone.0027593. Epub 2011 Nov 9.

22.

A novel recombinant soluble splice variant of Met is a potent antagonist of the hepatocyte growth factor/scatter factor-Met pathway.

Tiran Z, Oren A, Hermesh C, Rotman G, Levine Z, Amitai H, Handelsman T, Beiman M, Chen A, Landesman-Milo D, Dassa L, Peres Y, Koifman C, Glezer S, Vidal-Finkelstein R, Bahat K, Pergam T, Israel C, Horev J, Tsarfaty I, Ayalon-Soffer M.

Clin Cancer Res. 2008 Jul 15;14(14):4612-21. doi: 10.1158/1078-0432.CCR-08-0108.

23.

Human endogenous retrovirus (HERV-K) reverse transcriptase as a breast cancer prognostic marker.

Golan M, Hizi A, Resau JH, Yaal-Hahoshen N, Reichman H, Keydar I, Tsarfaty I.

Neoplasia. 2008 Jun;10(6):521-33.

24.

Diagnostic targeting of colon cancer using a novel fluorescent somatostatin conjugate in a mouse xenograft model.

Kostenich G, Oron-Herman M, Kimel S, Livnah N, Tsarfaty I, Orenstein A.

Int J Cancer. 2008 May 1;122(9):2044-9. doi: 10.1002/ijc.23353.

25.

Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells.

Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, Tsarfaty I, Hudson E, Jackson DG, Petillo D, Chen J, Resau JH, Teh BT.

Cancer Res. 2006 Nov 1;66(21):10365-76. Epub 2006 Oct 23.

26.

Mimp, a mitochondrial carrier homologue, inhibits Met-HGF/SF-induced scattering and tumorigenicity by altering Met-HGF/SF signaling pathways.

Leibowitz-Amit R, Tsarfaty G, Abargil Y, Yerushalmi GM, Horev J, Tsarfaty I.

Cancer Res. 2006 Sep 1;66(17):8687-97.

27.

In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.

Moshitch-Moshkovitz S, Tsarfaty G, Kaufman DW, Stein GY, Shichrur K, Solomon E, Sigler RH, Resau JH, Vande Woude GF, Tsarfaty I.

Neoplasia. 2006 May;8(5):353-63.

28.

HGF/SF increases tumor blood volume: a novel tool for the in vivo functional molecular imaging of Met.

Tsarfaty G, Stein GY, Moshitch-Moshkovitz S, Kaufman DW, Cao B, Resau JH, Vande Woude GF, Tsarfaty I.

Neoplasia. 2006 May;8(5):344-52.

29.

In search of drug treatment for genetic defects in the DNA damage response: the example of ataxia-telangiectasia.

Shiloh Y, Andegeko Y, Tsarfaty I.

Semin Cancer Biol. 2004 Aug;14(4):295-305. Review.

PMID:
15219622
30.

In situ activation pattern of Met docking site following renal injury and hypertrophy.

Dekel B, Biton S, Yerushalmi GM, Altstock RT, Mittelman L, Faletto D, Smordinski NI, Tsarfaty I.

Nephrol Dial Transplant. 2003 Aug;18(8):1493-504.

PMID:
12897086
31.

Grappling with metastatic risk: bringing molecular imaging of Met expression toward clinical use.

Hay R, Cao B, Tsarfaty I, Tsarfaty G, Resau J, Vande Woude G.

J Cell Biochem Suppl. 2002;39:184-93. Review.

PMID:
12552618
32.

Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.

Yerushalmi GM, Leibowitz-Amit R, Shaharabany M, Tsarfaty I.

Neoplasia. 2002 Nov-Dec;4(6):510-22.

33.

Effect of Candida albicans metabolite(s) on cellular actin.

Sandovsky-Losica H, Berdicevsky I, Tsarfaty I, Segal E.

FEMS Microbiol Lett. 2002 Sep 24;215(1):57-62.

34.

Engraftment and differentiation of human metanephroi into functional mature nephrons after transplantation into mice is accompanied by a profile of gene expression similar to normal human kidney development.

Dekel B, Amariglio N, Kaminski N, Schwartz A, Goshen E, Arditti FD, Tsarfaty I, Passwell JH, Reisner Y, Rechavi G.

J Am Soc Nephrol. 2002 Apr;13(4):977-90.

35.

Nuclear retention of ATM at sites of DNA double strand breaks.

Andegeko Y, Moyal L, Mittelman L, Tsarfaty I, Shiloh Y, Rotman G.

J Biol Chem. 2001 Oct 12;276(41):38224-30. Epub 2001 Jul 13.

36.

In vivo molecular imaging of met tyrosine kinase growth factor receptor activity in normal organs and breast tumors.

Shaharabany M, Abramovitch R, Kushnir T, Tsarfaty G, Ravid-Megido M, Horev J, Ron R, Itzchak Y, Tsarfaty I.

Cancer Res. 2001 Jun 15;61(12):4873-8.

38.

HGF/SF activates glycolysis and oxidative phosphorylation in DA3 murine mammary cancer cells.

Kaplan O, Firon M, Vivi A, Navon G, Tsarfaty I.

Neoplasia. 2000 Jul-Aug;2(4):365-77.

39.

Cellular actin is affected by interaction with Candida albicans.

Tsarfaty I, Sandovsky-Losica H, Mittelman L, Berdicevsky I, Segal E.

FEMS Microbiol Lett. 2000 Aug 15;189(2):225-32.

40.

Dominant negative Met reduces tumorigenicity-metastasis and increases tubule formation in mammary cells.

Firon M, Shaharabany M, Altstock RT, Horev J, Abramovici A, Resau JH, Vande Woude GF, Tsarfaty I.

Oncogene. 2000 May 11;19(20):2386-97.

41.

A mouse fibroblast line cycles between monolayer and spheroid forms, regulates Met and HGF expression, and releases an attachment and growth-promoting substance.

Halverson DO, Resau J, Faletto D, Fisher R, Anver M, Rong S, May JA, Tsarfaty I, Blair DG.

Cell Biol Int. 1999;23(4):257-74.

PMID:
10600235
42.

Alteration of Met protooncogene product expression and prognosis in breast carcinomas.

Tsarfaty I, Alvord WG, Resau JH, Altstock RT, Lidereau R, Bieche I, Bertrand F, Horev J, Klabansky RL, Keydar I, Vande Woude GF.

Anal Quant Cytol Histol. 1999 Oct;21(5):397-408.

PMID:
10560522
43.

Heterotopic endochondrial ossification with mixed tumor formation in C3(1)/Tag transgenic mice is associated with elevated TGF-beta1 and BMP-2 expression.

Maroulakou IG, Shibata MA, Anver M, Jorcyk CL, Liu Ml, Roche N, Roberts AB, Tsarfaty I, Reseau J, Ward J, Green JE.

Oncogene. 1999 Sep 23;18(39):5435-47.

44.

Alteration of actin organization by jaspamide inhibits ruffling, but not phagocytosis or oxidative burst, in HL-60 cells and human monocytes.

Fabian I, Halperin D, Lefter S, Mittelman L, Altstock RT, Seaon O, Tsarfaty I.

Blood. 1999 Jun 1;93(11):3994-4005.

PMID:
10339509
45.

Met-HGF/SF mediates growth arrest and differentiation in T47D breast cancer cells.

Ronen D, Altstock RT, Firon M, Mittelman L, Sobe T, Resau JH, Vande Woude GF, Tsarfaty I.

Cell Growth Differ. 1999 Feb;10(2):131-40.

46.

Morphogenetic effects of neuregulin (neu differentiation factor) in cultured epithelial cells.

Chausovsky A, Tsarfaty I, Kam Z, Yarden Y, Geiger B, Bershadsky AD.

Mol Biol Cell. 1998 Nov;9(11):3195-209.

47.

Met-HGF/SF: tumorigenesis, invasion and metastasis.

Vande Woude GF, Jeffers M, Cortner J, Alvord G, Tsarfaty I, Resau J.

Ciba Found Symp. 1997;212:119-30; discussion 130-2, 148-54. Review.

PMID:
9524767
48.

In vivo expression of inducible nitric oxide synthase in cerebellar neurons.

Minc-Golomb D, Yadid G, Tsarfaty I, Resau JH, Schwartz JP.

J Neurochem. 1996 Apr;66(4):1504-9.

PMID:
8627305
49.

Overexpression of human p21waf1/cip1 arrests the growth of chicken embryo fibroblasts transformed by individual oncogenes.

Givol I, Givol D, Rulong S, Resau J, Tsarfaty I, Hughes SH.

Oncogene. 1995 Dec 21;11(12):2609-18.

PMID:
8545118
50.

Immunogold labeling of oncogenic and tumor related proteins.

Rulong S, Zhou R, Tsarfaty I, Hughes S, Vande Woude G, Pinto da Silva P.

Microsc Res Tech. 1995 Jun 1;31(2):159-73. Review.

PMID:
7655089

Supplemental Content

Loading ...
Support Center